Which Chinese hospital has the most annual cycles? Reference for assisted reproduction center rankings

Metadata badge

Practitioner's Observation: The Real Logic Behind Annual Cycle Numbers

Having worked in the field of assisted reproduction for over a decade, I encounter a large number of similar questions every year. The annual cycle number – the total number of assisted reproduction treatment cycles completed by a reproductive center in one year – is indeed an important indicator of a center's scale, patient capacity, and operational maturity. However, it cannot simply be equated with "the best" or "the most suitable."

A high annual cycle number for a center usually means: clinicians have handled a large number of similar cases, leading to faster accumulation of experience; the embryology laboratory operates more proficiently with a more robust quality control system; and the nursing and coordination teams are more efficient in process management. These are indeed advantages of a high cycle volume. But the structure behind the cycle number – such as patient composition, technical approaches, success rate data, and whether it matches your specific condition – is what requires more attention.

The annual cycle number is a "scale indicator," not a "quality indicator." It can tell you "how much" a center does, but it cannot directly tell you "how well" it does it, nor can it tell you whether it is "suitable for you."

Which Chinese hospital has the most annual cycles

According to publicly available industry information and consensus over the years, CITIC Xiangya Reproductive and Genetic Hospital has ranked first nationwide for consecutive years in terms of annual assisted reproduction cycles, with over 50,000 cycles per year. Additionally, the following reproductive centers also rank among the top in China for annual cycles:

Note: The above data are publicly available reference ranges within the industry. For specific annual data, please refer to official releases from each center. Cycle statistics include oocyte retrieval cycles and frozen-thawed embryo transfer cycles.

The annual cycle numbers of these centers are all in the top tier domestically, but there are significant differences in their specialty areas, technical approaches, and patient demographics.

How doctors interpret the significance of annual cycle numbers

From a doctor's perspective, the value of annual cycle numbers is reflected in the following dimensions, but each dimension has its applicable boundaries:

• Clinical experience density: In centers with high cycle numbers, doctors encounter a wider variety of case types each year, leading to more efficient identification and management of complex situations. However, this does not equate to deep experience in all disease types.
• Laboratory stability: A high cycle number implies greater daily operational intensity in the embryology laboratory, necessitating a more stringent quality control system, resulting in a relatively lower probability of systemic deviations.
• Process efficiency: High-volume centers typically have more mature patient management pathways, potentially leading to shorter waiting times from initial consultation to starting a cycle, but individualized attention may be diluted.
• Research data accumulation: The center possesses larger datasets, facilitating clinical research. However, for individual patients, the focus should be on subgroup data that matches their specific condition.

When evaluating a center, doctors simultaneously consider three indicators: annual cycle number, clinical pregnancy rate, and live birth rate. All three are indispensable. Making a decision based solely on cycle number is medically incomplete.

Deep-seated reasons for differences in annual cycle numbers between hospitals

Even among large reproductive centers, differences in annual cycle numbers result from a combination of factors. The following are the most core dimensions:

Regional population and medical catchment area

Hospitals located in populous provinces or regional medical centers naturally have a larger patient base. For example, CITIC Xiangya in Changsha and The First Affiliated Hospital of Zhengzhou University in Henan are both in densely populated areas, attracting a large influx of patients from surrounding provinces. While Beijing and Shanghai have high local population density, medical resources are more dispersed, leading to significant patient分流.

Technical approach and patient structure

Different centers have different technical focuses, attracting different patient groups. For instance, Shanghai Ninth People's Hospital is renowned for mild stimulation protocols, attracting many patients of advanced age and with low ovarian reserve. CITIC Xiangya has deep expertise in genetic screening, attracting patients with genetic counseling needs. Differences in patient structure directly impact the composition of cycle numbers.

Medical insurance policies and affordability

The extent of coverage for assisted reproduction under local medical insurance reimbursement policies varies, influencing patients' geographical preferences when choosing a center. In regions with more open policies, local patients are more inclined to stay for treatment, indirectly affecting the distribution of cycle numbers among centers.

Center history and brand accumulation

CITIC Xiangya is one of the earliest centers to carry out assisted reproduction in China. Over two decades of brand building and word-of-mouth reputation have made it a top choice for patients seeking cross-regional treatment nationwide. This historical accumulation is a crucial foundation for its consistently high cycle numbers.

The most easily overlooked detail: Statistical scope of cycle numbers

When comparing annual cycle numbers between different hospitals, the most easily overlooked issue for patients is whether the statistical scope is consistent.

Different hospitals may use different statistical methods when publishing cycle numbers:

• Oocyte retrieval cycles: Only counts cycles where oocyte retrieval was actually performed, excluding frozen-thawed embryo transfer cycles.
• Embryo transfer cycles: Counts all cycles where embryo transfer was performed, including fresh and frozen embryo transfers.
• Clinical pregnancy cycles: Only counts cycles where clinical pregnancy was confirmed; this is an outcome indicator, not a process indicator.
• Total treatment cycles: May include the sum of intrauterine insemination (IUI) cycles and in vitro fertilization (IVF) cycles.

If Center A publishes "oocyte retrieval cycles" and Center B publishes "embryo transfer cycles," a direct comparison will lead to bias. When reviewing data, it is essential to confirm the statistical scope or make comparisons within the same scope.

Frequently asked questions

The most common pitfall: Blindly pursuing the "largest" while ignoring compatibility

In the decision-making path for assisted reproduction, the most common misconception is: "Choosing the center with the largest cycle number equals choosing the best treatment." The specific problems arising from this misconception include:

• Decreased patient experience: Ultra-large centers have a massive patient flow, potentially compressing the communication time doctors can allocate to each patient, reducing individualized attention. For complex cases requiring in-depth discussion, this may affect the precision of the treatment plan.
• Hidden costs of cross-regional medical care: Treatment in a different city requires multiple trips, significantly increasing transportation, accommodation, and time costs. If the high-volume center is too far away, the physical and psychological stress from traveling may offset some technical advantages.
• Ignoring compatibility of technical approaches: Different centers have differences in ovarian stimulation protocols, laboratory techniques, and embryo culture strategies. The methods a center excels at may not be suitable for your condition. For example, a patient suitable for a mild stimulation protocol might not receive the most tailored treatment at a center primarily using traditional long protocols.
• Judgment clouded by the "halo effect": The halo of being number one in annual cycles can easily make patients neglect rational analysis of their own condition, even abandoning treatment at a more suitable local center.

Handling special situations: Who needs to be more cautious in choosing

For the following groups, the reference weight of annual cycle numbers needs appropriate adjustment:

• Advanced age (≥40 years) with low ovarian reserve (AMH < 1.0): More suitable for centers experienced in mild or gentle stimulation protocols. Such techniques may be more mature in some medium-sized centers, whereas large centers, due to high patient volume, may lean towards standardized protocols.
• Recurrent implantation failure (RIF): Requires a center with in-depth capabilities for endometrial receptivity assessment, dynamic embryo development monitoring, and immunological evaluation. These capabilities are not perfectly correlated with cycle number.
• Need for PGT due to genetic disease risk: Prioritize centers with specialized experience in genetic counseling, embryo biopsy, and testing. A high cycle number does not necessarily mean deep expertise in genetics.
• High ovarian response / Polycystic Ovary Syndrome: Requires a center with mature protocols for OHSS prevention and individualized ovulation induction. This is more related to the center's clinical management processes than simply the cycle number.

How to choose: An actionable decision-making framework

If you are struggling with whether to go to the center with the most annual cycles, you can structure your decision by following these steps:

1. Clarify your core clinical characteristics: Age, AMH, FSH, antral follicle count, previous IVF history, presence of any known genetic risks.
2. List 2-3 candidate centers: Include strong comprehensive centers in your local area, as well as well-known cross-regional centers.
3. Compare subgroup data of candidate centers: Look for pregnancy/live birth rate data published by each center for populations similar to your condition. If data is not public, inquire through doctor consultations or patient communities for general information.
4. Assess feasibility of treatment: How many trips are needed for the cross-regional center? How long is each stay? Is the total budget within your acceptable range?
5. Have an initial consultation: Personally experience the doctor's communication style and the center's processes to determine if they meet your needs.

The annual cycle number can serve as an initial screening indicator, but it should not be the sole basis for decision-making.